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The Bacillus subtilis AraR transcription factor represses at least 13 genes required for the extracellular
degradation of arabinose-containing polysaccharides, transport of arabinose, arabinose oligomers, xylose, and
galactose, intracellular degradation of arabinose oligomers, and further catabolism of this sugar. AraR
exhibits a chimeric organization comprising a small N-terminal DNA-binding domain that contains a winged
helix-turn-helix motif similar to that seen with the GntR family and a larger C-terminal domain homologous
to that of the LacI/GalR family. Here, a model for AraR was derived based on the known crystal structures of
the FadR and PurR regulators from Escherichia coli. We have used random mutagenesis, deletion, and
construction of chimeric LexA-AraR fusion proteins to map the functional domains of AraR required for DNA
binding, dimerization, and effector binding. Moreover, predictions for the functional role of specific residues
were tested by site-directed mutagenesis. In vivo analysis identified particular amino acids required for dimer
assembly, formation of the nucleoprotein complex, and composition of the sugar-binding cleft. This work
presents a structural framework for the function of AraR and provides insight into the mechanistic mode of
action of this modular repressor.
The transcription factor AraR controls the expression of
several Bacillus subtilis genes encoding enzymes and permeases
involved in the degradation of arabinose-containing polysac-
charides, uptake of L-arabinose (and possibly arabinose oli-
gomers), xylose, and galactose, and further intracellular catab-
olism of arabinose and arabinose oligomers. The arabinose
(ara) regulon comprises at least 13 genes (Fig. 1), the araAB
DLMNPQ–abfA operon (43), the divergently arranged araE/
araR genes (42, 45) located in distinct regions of the B. subtilis
chromosome, and the genes abnA and xsa positioned immedi-
ately upstream and 23 kb downstream from the operon, re-
spectively (57). The first three genes of the arabinose meta-
bolic operon, araA, araB, and araD, encode the enzymes
required for the intracellular conversion of L-arabinose into
D-xylulose 5-phosphate, which is further catabolized through
the pentose phosphate pathway (41). The function of araL and
araM is unknown, and genes araNPQ encode components of
an ABC-type transporter most likely involved in the uptake of
arabinose oligomers (43, 45). The product of the araE gene
is a permease, the main transporter of arabinose into the
cell (45), that is also responsible for the uptake of xylose and
galactose (14). The araR gene encodes the regulatory pro-
tein of the system (27). The last gene of the metabolic
operon, abfA, and the xsa gene most probably encode ara-
binofuranosidases involved in the intracellular degradation
of arabinose oligomers (36). The abnA gene encodes an
extracellular endo-arabinanase that degrades the arabinose
homoglycan arabinan (16).
The pathways of L-arabinose utilization in B. subtilis and
Escherichia coli are identical, and the catabolic enzymes are
functionally homologous (7, 18, 41). However, in these two
model microorganisms for gram-positive and gram-negative
bacteria, respectively, the regulators have distinct phylogenetic
origins and well-characterized different modes of action, out-
lining the divergent evolutionary pathways of catabolic en-
zymes and regulatory proteins. The B. subtilis ara regulon,
comprising five arabinose-responsive promoters (ParaABD
LMNPQ-abfA, PabnA, Pxsa, ParaE, ParaR), is under the neg-
ative control of AraR (36, 42, 45), whereas in E. coli the
regulatory protein, AraC, activates four arabinose-responsive
promoters (ParaBAD, ParaE, ParaFGH, ParaJ) and represses
the expression of its own promoter ParaC (46, 47). The AraC
protein, composed of an N-terminal arabinose-binding and
-dimerization domain and a C-terminal DNA-binding domain
(DBD), uses a binary switch mechanism of allosteric regula-
tion. In the absence of arabinose, a peptidyl arm from the
effector-binding and -dimerization domain binds to the DBD.
Consequently, in the dimer the orientation of the DBDs with
respect to each other favors their binding to two distant DNA
sites causing the formation of a loop. When the effector is
present, the arms bind over arabinose, freeing the DBDs,
which bind to two adjacent DNA sites (references 46 and 47
and references therein).
The B. subtilis AraR protein recognizes and binds to eight
specific DNA operator sites within the five different promoters
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(ParaABDLMNPQ-abfA, PabnA, Pxsa, ParaE, ParaR), as de-
termined by DNaseI footprinting studies and mutation analysis
(26, 27, 36). However, two distinct modes of transcriptional
repression are observed that might reflect different physiolog-
ical requirements. A high level of repression is achieved by
cooperative binding of AraR to two in-phase operators con-
comitant with DNA looping within the promoter region of the
ara metabolic operon, and the genes xsa and araE, that ensures
tight control of expression of intracellular enzymes and trans-
port systems. On the other hand, binding to a single operator
that autoregulates araR expression and represses abnA expres-
sion is less effective, resulting in flexible control that allows
basal transcription of both genes (26, 27, 36). Binding of arab-
inose to AraR is presumed to result in a conformational
change that inhibits or prevents AraR-DNA binding, leading
to transcriptional derepression of the regulon. AraR is a 362-
residue and 40-kDa protein that exhibits a mosaic organization
comprising two domains of different origins (27, 42). The N-
terminal region (residues 1 to 70) contains a helix-turn-helix
(HTH) consensus signature sequence of the GntR family of
bacterial regulatory proteins (10), while the C-terminal region
(residues 71 to 362) displays significant similarity to that of the
LacI/GalR family of bacterial regulators (56). This modular
architecture, the predicted HTH motif, and the amino acid
similarities suggest that AraR is composed of two functional
domains: a smaller N-terminal domain responsible for the
DNA-binding specificity and a larger C-terminal domain in-
volved in effector binding and oligomerization. To date, in
addition to AraR, 21 proteins presenting this mosaic modular
association in different bacteria have been sequenced. To-
gether they constitute one of the six GntR subfamilies typified
by AraR (17, 38). However, no functional studies have been
reported for these AraR-like proteins (http://www.sanger.ac.uk
/Software/Pfam). Here, we combined random mutagenesis of
the araR gene and site-directed mutagenesis guided by molec-
ular modeling techniques to identify the residues within AraR
that are involved in DNA binding, dimer assembly, and arabi-
nose binding. The functional relevance of the identified amino
acids was evaluated by genetic analysis. This structure-function
analysis of AraR provides insights into the roles of amino acid
residues involved in AraR nucleoprotein complex assembly
and effector binding.
MATERIALS AND METHODS
Strains and growth conditions. B. subtilis strains used in this study (Table 1)
were grown in liquid Luria-Bertani (LB) medium (25) or C minimal medium (32)
and solid sugar-free agar (SFA) medium (LabM) or LB broth solidified with
1.6% agar. Chloramphenicol (5 g ml1), kanamycin (10 g ml1), erythromycin
(1 g ml1), and neomycin (1 g ml1) were added when appropriate. The Amy
phenotype was tested on tryptose blood agar base medium (Difco) plates con-
taining 1% of potato starch after overnight incubation, and starch hydrolysis was
detected by flooding the plates with an I2-KI solution as described previously
(42). Escherichia coli DH5 (Gibco BRL) was used for routine molecular cloning
work, and E. coli SU101 (5) was used as the host for the analysis of chimeric
LexA-AraR fusions. E. coli strains were grown on LB broth and LB broth
solidified with 1.6% agar or MacConkey agar medium (Difco) plates, with am-
picillin (100 g ml1), chloramphenicol (20 g ml1), kanamycin (30 g ml1),
tetracycline (12 g ml1), and IPTG (isopropyl--D-thiogalactopyranoside) (1
mM) added as appropriate. The B. subtilis and E. coli cells were transformed as
described previously (26).
DNA manipulations and sequencing. DNA manipulations were carried out as
described previously (40). Restriction enzymes were purchased from MBI Fer-
mentas, New England Biolabs, or Roche and used according to manufacturer’s
instructions. DNA was eluted from agarose gels using the GeneCleanII kit
(Bio101) or the MERmaid kit (Bio101). PCRs were performed in a GeneAmp
PCR system 2400 (Perkin-Elmer), and PCR products were purified using a
QIAquick PCR purification kit (QIAGEN). DNA was sequenced using a Seque-
nase V 2.0 kit (USB) or an ABI PRISM BigDye terminator ready-reaction cycle
sequencing kit (Applied Biosystems).
Random and site-directed mutagenesis of araR. Plasmid pLS30 was used as a
DNA template in random mutagenesis experiments and was constructed as
follows: a 2,920-bp PvuII-PvuII region from pSN32 (27) containing the lacZ gene
was removed by restriction and autoligation, producing pLS21. The unique BglII
site present in this plasmid was eliminated by fill-in to yield pLS22. Insertion of
a 1,446-bp EcoRI-BamHI fragment from pLM3 (43), containing an entire copy
of the araR gene and a truncated copy of araE, into pLS22 EcoRI-BamHI
yielded pLS24. Finally, the creation of two additional restriction sites (BglII or
KpnI) in araR by silent mutagenesis was accomplished by PCR amplification
using pLS24 as a template and the pairs of primers ARA200-ARA203 and
ARA201-ARA202 (Table 2) in two separate experiments; the resulting 187-bp
and 8.1-kb PCR products, respectively, were digested with BglII or KpnI and
ligated to yield pLS30, at which point the presence of both restriction sites and
the absence of further mutations were checked by sequencing.
To facilitate cloning procedures and sequence analysis, the araR allele was
divided into three fragments flanked by unique restriction sites (162-bp BglII-
KpnI, 324-bp KpnI-MluI, and 664-bp MluI-EcoRI); random mutagenesis of araR
was accomplished by PCR amplification of each fragment with flanking primers
ARA200-ARA203, ARA202-ARA10, and ARA95-ARA1 (Table 2), respec-
tively, under conditions that increased the frequency of Taq polymerase error to
0.4% (19). The PCR contained 1 PCR buffer (MBI Fermentas), 0.5 mM
primers, 0.1 to 1 mg ml1 pLS30 DNA, 1 mM deoxynucleoside triphosphates, 6.6
mM MgCl2, 0.5 mM MnCl2, and 1 l of Taq polymerase (MBI Fermentas) in a
100-l total volume. PCR products were cleaved with the appropriate restriction
enzymes, and the resulting fragment was cloned back into pLS30 to replace the
equivalent region of the wild-type araR allele. The recombinant plasmids were
transformed into E. coli DH5 competent cells, yielding three distinct libraries of
araR mutations. Ten isolates from each group of approximately 800 colonies
were picked randomly to evaluate the efficiency of mutagenesis by sequencing
the mutagenized insert. The determined value of 0.13% is lower than the 2%
found by Leung et al. (19). The remaining E. coli colonies of each library were
pooled, and linearized plasmid DNA was used in separate experiments to trans-
form B. subtilis IQB350 (Table 1). This procedure allowed the integration of the
araR mutant alleles into the chromosome of B. subtilis, at the amyE locus, via
double recombination. Phenotypic analysis of constitutive AraR mutants and
AraRs superrepressor mutants was accomplished, respectively, through screen-
ing for Lac colonies in SFA plates with X-Gal (5-bromo-4-chloro-3-indolyl--
D-thiogalactopyranoside) (0.02%) and for Lac colonies in the same medium
with 0.2% L-arabinose. Chromosomal DNA from colonies displaying the ex-
pected phenotype was used as a template to amplify the mutagenized region of
the araR allele, which was subsequently cloned back into pLS30 as described
FIG. 1. Schematic representation of the B. subtilis arabinose regu-
lon. Expression of all ara genes is repressed by AraR and induced by
arabinose. Distinct mechanisms of AraR binding to its operator re-
gions in the different promoters allow a tight or flexible control of the
system. AbfA, AbnA, and Xsa are enzymes involved in the degradation
of arabinose-containing polysaccharides. AraE is a permease, the main
transporter of arabinose into the cell, also responsible for the uptake
of xylose and galactose. AraNPQ are components of an ABC-type
high-affinity transport system for arabinose and/or arabinose oli-
gomers. Intracellular catabolism of arabinose into xylulose 5-P, which
is further catabolized through the pentose phosphate pathway, is car-
ried out by AraA, AraB, and AraD. The function of AraL and AraM
is unknown.
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above and sequenced. The resulting plasmids bear the following mutations lead-
ing to single-amino-acid substitutions F37S, Q61R, L33S, T87I, S53P, H226R,
I308T, P319L, C271R, R285K, I82T, L157R, S146R, and T117A (see Table 1).
In a previous work a collection of B. subtilis strains carrying mutations that
mapped on the araR region was characterized (33, 44). Chromosomal DNA from
these strains was amplified by PCR, using oligonucleotides ARA13 and ARA18,
and sequenced. Four araR alleles containing single missense mutations (E142K,
G215V, G215D, and G138E) were subsequently amplified by PCR with primers
ARA202 and ARA10 for E142K and G138E or primers ARA15 and ARA93 for
G215V and G215D. The resulting KpnI-MluI or MluI-EcoRI fragments were
subcloned into pLS30 (see Table 1).
To create an in-frame deletion in the 5 region of araR the KpnI site in pLS30
was changed for a second BglII site by amplification of the araR allele by use of
oligonucleotides ARA10 and ARA94 (Table 2). The PCR product was digested
with MluI and BglII and cloned back into pLS30 MluI-BglII to generate pIF8,
which carries an in-frame deletion comprising amino acids (aa) 13 to 65.
Amino acid substitutions in AraR were made by the QuikChange (Stratagene)
site-directed method using plasmid pIF38 as the template. This plasmid is a
pLS30 derivative obtained by digestion with EcoRI and Eco47III to remove a
3.4-kb fragment that includes the cat gene and amyE back sequences. Mutagenic
oligonucleotides used (see Table 2) carried the modified codon in the center.
The regions containing the target nucleotides (296-bp BamHI-BglII, 486-bp
BglII-MluI, or 1,001-bp MluI-PvuII fragments) were subcloned into pLS30 and
the mutations confirmed by sequencing. The linearized plasmids were used to
transform B. subtilis receptor strain IQB350 (Table 1), and the Lac phenotype
was checked as described above. Substitutions R45A and H318A were generated
by a similar method using pLS30 as the template. After ligation and linearization,
the mutagenized plasmids were also used to transform B. subtilis strain IQB350.
TABLE 1. B. subtilis strains used in this work
Straina Genotype Relevantphenotype Source
IGCg701 metB10 lys3 araR E142K Ara Paveia and Archer (33)
IGCg711 metB10 lys3 araR G215V Ara/ Paveia and Archer (33)
IGCg715 metB10 lys3 araR G215D Ara/ Paveia and Archer (33)
IGCg735 metB10 lys3 araR G138E Ara(Con)b Sa´-Nogueira et al. (44)
IQB101 araAB-lacZ erm Ara LacZ Sa´-Nogueira et al. (43)
IQB350 araR::kan araAB-lacZ erm Ara LacZ pLM83IQB101c
IQB351 araR::kan araAB-lacZ erm amyE::araR cat LacZ pLS243IQB350
IQB352 araR::kan araAB-lacZ erm amyE::araR cat LacZ pLS303IQB350
IQB355 araR::kan araAB-lacZ erm amyE::araR F37S cat LacZ pIF13IQB350
IQB356 araR::kan araAB-lacZ erm amyE::araR Q61R cat LacZ pIF23IQB350
IQB357 araR::kan araAB-lacZ erm amyE::araR L33S cat LacZ pIF33 IQB350
IQB358 araR::kan araAB-lacZ erm amyE::araR 13–65 cat LacZ pIF83IQB350
IQB364 araR::kan araAB-lacZ erm amyE::araR T87I cat LacZ pIF133IQB350
IQB368 araR::kan araAB-lacZ erm amyE::araR S53P cat LacZ pIF173IQB350
IQB371 araR::kan araAB-lacZ erm amyE::araR H226R cat LacZ pIF273IQB350
IQB372 araR::kan araAB-lacZ erm amyE::araR I308T cat LacZ pIF283IQB350
IQB373 araR::kan araAB-lacZ erm amyE::araR P319L cat LacZ pIF293IQB350
IQB374 araR::kan araAB-lacZ erm amyE::araR C271R cat LacZ pIF303IQB350
IQB375 araR::kan araAB-lacZ erm amyE::araR R285K cat LacZ pIF313IQB350
IQB376 araR::kan araAB-lacZ erm amyE::araR I82T cat LacZ pRS13IQB350
IQB377 araR::kan araAB-lacZ erm amyE::araR L157R cat LacZ pRS23IQB350
IQB378 araR::kan araAB-lacZ erm amyE::araR S146R cat LacZ pRS33IQB350
IQB379 araR::kan araAB-lacZ erm amyE::araR T117A cat LacZ pRS43IQB350
IQB398 araR::kan araAB-lacZ erm amyE::araR E142K cat LacZ pIF323IQB350
IQB399 araR::kan araAB-lacZ erm amyE::araR G215V cat LacZ pIF333IQB350
IQB500 araR::kan araAB-lacZ erm amyE::araR G215D cat LacZ pIF343IQB350
IQB501 araR::kan araAB-lacZ erm amyE::araR D211G cat LacZ pIF353IQB350
IQB502 araR::kan araAB-lacZ erm amyE::araR G138E cat LacZ pIF363IQB350
IQB510 araR::kan araAB-lacZ erm amyE::araR F94A cat LacZ pSC93IQB350
IQB511 araR::kan araAB-lacZ erm amyE::araR D212A cat LacZ pSC103IQB350
IQB512 araR::kan araAB-lacZ erm amyE::araR Q214A cat LacZ pSC113IQB350
IQB516 araR::kan araAB-lacZ erm amyE::araR R218L cat LacZ pIF463IQB350
IQB517 araR::kan araAB-lacZ erm amyE::araR D301N cat LacZ pIF473IQB350
IQB518 araR::kan araAB-lacZ erm amyE::araR I89A cat LacZ pVAB13IQB350
IQB519 araR::kan araAB-lacZ erm amyE::araR L114A cat LacZ pVAB23IQB350
IQB520 araR::kan araAB-lacZ erm amyE::araR R99A cat LacZ pVAB33IQB350
IQB528 araR::kan araAB-lacZ erm amyE::araR Y92F cat LacZ pVAB53IQB350
IQB529 araR::kan araAB-lacZ erm amyE::araR F305A cat LacZ pVAB63IQB350
IQB563 araR::kan araAB-lacZ erm amyEaraR R45A cat LacZ pLS30(mut)d3IQB350
IQB569 araR::kan araAB-lacZ erm amyE::araR E102Q cat LacZ pIF683IQB350
IQB570 araR::kan araAB-lacZ erm amyE::araR H318A cat LacZ pLS30(mut)d3IQB350
IQB579 araAB-lacZ ery amyE::Pspac Ppcn-lacI neo LacZ pGR633IQB101
IQB580 araAB-lacZ ery amyE::Pspac-araR Ppcn-lacI neo LacZ pIF813IQB101
IQB581 araAB-lacZ ery amyE::Pspac-araR R45A Ppcn-lacI neo LacZ pIF823IQB101
IQB584 araAB-lacZ ery amyE::Pspac-araR F94A Ppcn-lacI neo LacZ pIF863IQB101
IQB585 araAB-lacZ ery amyE::Pspac-araR L114A Ppcn-lacI neo LacZ pIF873IQB101
IQB591 araAB-lacZ ery amyE::Pspac-araR I89A Ppcn-lacI neo LacZ pIF1033IQB101
IQB592 araAB-lacZ ery amyE::Pspac-araR F305A Ppcn-lacI neo LacZ pIF1053IQB101
a All strains derive from B. subtilis 168T (prototroph [43]) except IGCg701, IGCg711, IGCg715, and IGCg735, which derive from BR151 (43).
b Con, constitutive.
c The arrows indicate transformation and point from donor DNA to recipient strain. Transformation was always carried out with linearized DNA.
d Mutagenized (mut) pLS30 DNA was used as the donor DNA (see Materials and Methods).
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The presence of the mutation was verified by sequencing the araR allele in the
resulting strains by PCR amplification of chromosomal DNA with oligonucleo-
tides ARA1 and ARA4.
Construction of chimeric LexA-AraR. The araR coding sequence comprised in
pLS30 was amplified with oligonucleotides ARA96 and ARA98, containing XhoI
and PstI sites, respectively. After cleavage with these enzymes, the resulting 1-kb
PCR fragment was inserted into pSR658 XhoI-PstI (5) to yield pSC1, which
carries an in-frame fusion of the entire AraR with LexA-DBD (LexA-DBD
AraR1–362). To construct chimeras containing truncated versions of AraR, araR-
specific oligonucleotides ARA142 to ARA144 (Table 2) were synthesized to
engineer XhoI or SacI sites and used in amplifications with pSC1 as the template.
Insertion of the PCR products into pSR658, digested with the appropriate
enzymes, generated plasmids pSC3 (LexA-DBD AraR76–362), pSC4 (LexA-DBD
AraR160–362), and pSC5 (LexA-DBD AraR258–362). Construction of the pSR658
derivatives containing araR alleles harboring the single mutation L114A or the
double mutation I89AL114A was accomplished as follows. Elimination of the
StyI site from pSR658 by fill-in resulted in pVAB7, where the wild-type allele was
subsequently cloned as described above for pSC1, creating pVAB8. Substitution
of the 514-bp StyI-BglII region of araR in pVAB8 for the corresponding region
of the alleles contained in pVAB1 or pVAB2 yielded, respectively, pIF109 or
pVAB10, which carry mutated allele I89A or L114A. To obtain the double
mutant I89AL114A, the 286-bp AvaI-AvaI fragment from pVAB10 was ex-
changed for the same region in pIF109, yielding pIF122. All the new constructs
bearing the missense mutations and in-frame fusions were confirmed by sequenc-
ing. The Lac phenotype of the E. coli strains harboring these plasmids was
checked after growth in MacConkey agar plates (Difco) with the appropriate
antibiotics.
Construction of Pspac-araR fusions for B. subtilis transdominance assays. The
wild-type araR allele was amplified by PCR using pLS30 as the template and
oligonucleotides ARA183 and ARA95, which create XbaI and EcoRI sites at the
5 and 3 end of the gene. The DNA fragment was digested with these enzymes
and inserted into the same sites of pBKSII(), generating pIF79. DNA frag-
ments from araR alleles containing the mutation R45A, I89A, L114A, or F94A
were amplified using chromosomal DNA from strain IQB563, pVAB1, pVAB2,
or pSC9, respectively, with primers ARA183 and ARA10, digested with XbaI
and MluI, and subcloned into pIF79. For mutation F305A, primers ARA93 and
ARA95 were used and the fragment MluI-EcoRI was subcloned into pIF79. All
these alleles were placed under the control of the Pspac promoter (11) by
digestion of the pIF79 derivatives with XbaI and ClaI and insertion of the
fragments into pGR63 XbaI-ClaI (37). All mutations were confirmed by DNA
TABLE 2. Oligonucleotides used in this work
Oligonucleotide Site-directedsubstitutiona Sequence (533)
b
ARA1 (39)TAAGGGTAACTATTGCCG(22)
ARA4 (184)TTCTTCATTTCCCTGCCCTCCCG(162)
ARA10 (622)GAGAAAGCAAATGCTCCGC(604)
ARA13 (210)CATTTGGTTCTAATTGAGTTGG(189)
ARA15 (430)CATATTGACGGACTCATCG(448)
ARA18 (1133)CCCAAAGCTTGCTGAATTTATTCATTCAGTTTTCGTGC(109)6
ARA93 (1197)GACAGAATTCGTTCGTTG(1214)
ARA94 (215)GAGAGATCTTTGTCGCTTCAC(235)
ARA95 (460)AAAAGCGCCCTTCAAACC(477)
ARA96 (17)GAGGACTCGAGATGTTACC(35)
ARA98 (1127)CATTGCTGCAGTTATTCATTCAG(1105)
ARA142 (247)TCAGCGCTCGAGTCCAATAAAACGATC(273)
ARA143 (502)TTGGAGCTCAACGGCATTCCTTTTGCG(528)
ARA144 (796)ACACTCGAGAAAAACAGCAAGCACATGCC(824)
ARA155 R218L (fwd) (661)GACACACAAGGCGTGAAACTGATGAACGG(689)
ARA156 R218L (rev) (687)GTTCATCAGTTTCACGCCTTGTGTGTCATCAG(656)
ARA157 D301N (fwd) (921)CGGGTACAATGATTCACATTTCGC(944)
ARA158 D301N (rev) (944)GCGAAATGTGAATCATTGTACCCG(921)
ARA159 F94A (fwd) (298)GACTATATTGCCCCGAGCATCATC(321)
ARA160 F94A (rev) (318)GATGATGCTCGGGGCAATATAGTC(298)
ARA161 D212A (fwd) (655)GCTGATGCAACACAAGGCGTGAAACG(680)
ARA162 D212A (rev) (680)CGTTTCACGCCTTGTGTTGCATCAGC(655)
ARA163 Q214A (fwd) (658)GATGACACAGCAGGCGTGAAACG(680)
ARA164 Q214A (rev) (680)CGTTTCACGCCTGCTGTGTCATC(658)
ARA169 L114A (fwd) (359)CTATGCTTGCGACAAGCACAAACAAC(384)
ARA170 L114A (rev) (375)GCTTGTCGCAAGCATAGAATACCC(352)
ARA171 I89A (fwd) (284)CAACTTACGCATCAGACTATATTTTCCC(311)
ARA172 I89A (rev) (310)GGAAAATATAGTCTGATGCGTAAGTTGTC(282)
ARA173 R99A (fwd) (314)GCATCATCGCAGGAATCGAGTCC(336)
ARA174 R99A (rev) (334)ACTCGATTCCTGCGATGATGCTC(312)
ARA175 Y92F (fwd) (291)CATATCAGACTTTATTTTCCCGAGC(315)
ARA176 Y92F (rev) (315)GCTCGGGAAAATAAAGTCTGATATG(291)
ARA177 F305A (fwd) (928)GATGATTCACATGCCGCCCAAATC(951)
ARA178 F305A (rev) (951)GATTTGGGCGGCATGTGAATCATC(928)
ARA181 H318A (fwd) (968)CCTCTGTCAAAGCTCCGAAATCAGTGC(994)
ARA182 H318A (rev) (992)ACTGATTTCGGAGCTTTGACAGAGG(968)
ARA183 AAATCTAGAATTTTGGAGGAATGGATATGTTACC(35)
ARA200 (49)GTAAAAGAAGAGATCTCGTCTTGGATTAATCAAGG(83)
ARA201 (72)CCAAGACGAGATCTCTTCTTTTACTTGCGCG(42)
ARA202 (214)GGAGGTACCTTTGTCGCTTC(233)
ARA203 (235)GTGAAGCGACAAAGGTACCTCCG(213)
ARA242 R45A (fwd) (148)CGGCATACCATCGCGAAAGCGATCGGAGAC(177)
ARA243 R45A (rev) (177)GTCTCCGATCGCTTTCGCGATGGTATGCCG(148)
a Amino acid substitution obtained and direction of amplification of oligonucleotide, forward (fwd) or reverse (rev).
b The number(s) within the primer sequence refers to the position of the sequence relative to the transcription start site of araR, except in ARA1, where it indicates
the position in pLS30 relative to the EcoRI site (1). Restriction sites or modified codons used in site-directed mutagenesis are underlined.
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sequencing, and linearized plasmids were used in separate experiments to trans-
fer the Pspac-araR fusions into the chromosome of B. subtilis IQB101 (Table 1),
at the amyE locus, via double recombination.
-Galactosidase assays. B. subtilis strains were grown in C minimal medium
supplemented with 1% casein hydrolysate in the presence and absence of 0.4%
(wt/vol) L-arabinose as previously reported (43). For the transdominance assays
of mutant araR alleles, induction of the Pspac promoter was accomplished with
the addition of 0.5 mM IPTG. Samples of cell culture were collected and ana-
lyzed 2 h after the addition of L-arabinose. -Galactosidase activity was measured
and expressed in Miller units as described previously (43). The ratio of the levels
of -galactosidase activity determined in the presence and absence of inducer
was taken as a measure of AraR repression in the analyzed strains (repression
factor). Growth of E. coli strains for quantification of repression was carried out
as described previously (5), and samples of cell culture were collected and
analyzed 2 h after they reached an optical density at 600 nm of 	0.2.
Immunoblotting of cell extracts. B. subtilis strains were grown as described for
the -galactosidase assays (see above), and 8 ml of cell culture was harvested 2 h
after induction. After resuspension in lysis buffer (500 mM KCl, 20 mM HEPES-
K, 10 mM EDTA, 1 mM dithioerythritol, 10% glycerol, 1 mg ml1 lysozyme)
and incubation at 37°C for 10 min, cells were subjected to 3 cycles of freezing in
liquid N2 and thawing at 37°C. Benzonase (Merck) (5 U) was added, and
incubation was continued for 10 min. After 45 min of centrifugation at 13,000
rpm, samples of the soluble fraction containing 20 g of protein were resolved on
12.5% sodium dodecyl sulfate-polyacrylamide gel electrophoresis gels. Gels were
transferred for 1 h at 100 V to nitrocellulose membranes, and blots were devel-
oped with anti-AraR-MBP2* serum (27) by use of an ECL detection system
(Amersham Biosciences) as described by the manufacturer. Protein concentra-
tions were determined using a Bio-Rad kit.
Multiple sequence alignment. We used the ClustalW 1.82 program (53) with
the default parameters to perform multiple alignments of amino acid sequences
of AraR and nine AraR-like proteins. Similarly, the sequences of N-terminal
regions of these 10 AraR-like proteins and 20 other members of the GntR family
(Pfam PF00392) or the C-terminal regions of the AraR-like proteins and 20
other members of periplasmic binding proteins and sugar binding domain of the
LacI/GalR family (Pfam PF00532 [Peripla_BP_1]) were aligned to score amino
acid similarities. Identification of homologous residues was carried out as de-
scribed by Kraus et al. (13). Residues were considered characteristic for the
GntR family or the Peripla_BP_1 family when at least 75% of the 30 entries
shared identical residues in one position. Amino acids that are typical of the
AraR-like proteins are identical in 75% of the 10 AraRs and are found in less
than 25% of the other members of the GntR family or the Peripla_BP_1 family.
Modeling AraR. Since no significant hits for the whole AraR sequence were
found when searching the structural databases for sequence homologues of the
complete AraR, the N- and C-terminal domains cannot be modeled together.
However, the situation is different when one tries to find homologues for the two
domains separately. For the N-terminal domain of AraR we found that the
N-terminal domain of the structurally characterized FadR (54), a fatty acid-
responsive transcription factor from E. coli, displays some homology (28% iden-
tity). For this protein there is also a structure bound to DNA (58) which is quite
helpful in characterizing potentially important residues for the DNA interaction
on AraR. Therefore, this part of the structure of FadR (PDB code 1HW1;
without DNA) was used to derive the structure of the N-terminal domain of
AraR (the first 68 residues). The C-terminal domain of AraR shows some
homology (28% identity) with the structurally characterized C-terminal domain
of the purine repressor PurR (29, 49, 50), which was also determined in the
DNA-bound and -free forms. In this case, in contrast to the results seen with the
N-terminal domain of FadR, the DNA-bound and DNA-free conformations are
substantially different, even in the C-terminal domain (which does not contact
DNA). Therefore, we considered use of the DNA-bound form (PDB code
1QPZ) to model the C-terminal part of AraR to be safer. The program MOD
ELLER (39), version 6.1, was used for deriving the structures of both domains of
AraR (examining the dimers). The initial alignments were optimized through
several modeling cycles until a good quality model for the unknown structure was
achieved. The quality was assessed by examining the restraint violations reported
by MODELLER (39) and a Ramachandran analysis performed by the program
PROCHECK (15). The final model of the N-terminal domain has 94.6% of the
residues in the most-favored regions and 5.4% in additional allowed regions.
There were no residues in generously allowed or in disallowed regions. The final
model of the C-terminal domain has 91.1% of the residues in the most-favored
regions, 7.6% in additional allowed regions, and 0.8% in generously allowed and
0.6% (3 residues) in disallowed regions. Some of the residues presenting prob-
lems already had them in the template structure. In the modeled C-terminal
domain, given that the binding of arabinose depends heavily on side chain
conformations, we decided to use a better method to predict them with more
accuracy. For that method we used side chain prediction methods developed
previously (22, 24), tailored specifically for structures obtained using comparative
modeling (and therefore containing some backbone conformation errors) (23).
These methods use a backbone-dependent rotamer library, and in this case we
used the “Direct” strategy (see reference 23 for details). These methods were
applied to the C-terminal dimer. The resulting conformation was then energy
minimized using GROMOS96 (51, 55), keeping the backbone fixed to produce
the final model that was going to be used in the analysis.
Arabinose was built in the active site by use of the structure of the ribose-
binding protein (PDB code 2DRI) (3) that shows some homology with AraR and
contains ribose in the binding site. The arabinose was optimized on the binding
site of AraR after some manual adjustments and energy minimization.
RESULTS
AraR-like proteins and AraR modeling. AraR exhibits sig-
nificant similarity to the LacI/GalR family of bacterial regula-
tors (56). The similarity does not extend to the N-terminal
region, which is related to the HTH consensus signature se-
quence of the GntR family of bacterial regulatory proteins
(10). Nine orthologs displaying more than 40% amino acid
identity with B. subtilis AraR occur in eight other gram-positive
bacteria. To obtain a framework for the evaluation of AraR
functional analysis, we aligned the sequences of these 10 AraR-
like proteins and 20 other members of the GntR family (Pfam
PF00392 [N-terminal region]) or 20 members of periplasmic
binding proteins and sugar-binding domain of the LacI/GalR
family (Pfam PF00532 [Peripla_BP_1]) and scored amino acid
similarities (see Materials and Methods). The results are sum-
marized in Fig. 2, where only three members of the non-AraR
sequence group are shown. Amino acids that are typical of the
AraR-like proteins are identical in 75% of the 10 AraRs and
are found in less than 25% of the other members of the GntR
family or the Peripla_BP_1 family. The identical residues in
AraR-like proteins were found scattered throughout the entire
sequence, although some clusters are located in the C-terminal
domain of the proteins (positions 90 to 218 in AraR in B.
subtilis) (Fig. 2).
To obtain a more detailed structure-function correlation, a
model for the AraR dimer was built that allowed the identifi-
cation of amino acids potentially involved in effector binding,
dimerization, and DNA binding (Fig. 3A, B, and C) (coordi-
nates of the models are available; see the supplemental mate-
rial). However, due to the chimeric organization of AraR the
N- and C-terminal domains cannot be modeled together. The
N-terminal domain of the structurally characterized FadR
(54), a fatty acid-responsive transcription factor from E. coli,
was used to derive the structure (the first 68 residues) of the
N-terminal domain of AraR. The C-terminal domain of the E.
coli purine repressor PurR (29, 49, 50) was used to model the
C-terminal part of AraR (see Materials and Methods). The
effector-binding domain of the members from the LacI/GalR
family is structurally analogous to those of periplasmic-binding
proteins despite the generally low level of sequence identity
between these proteins (9, 15, 20). The definition of the arabi-
nose-binding pocket in AraR was based on the structure of
D-ribose-binding protein from E. coli (28).
LexA-AraR chimeras identify the dimerization domain of
AraR. We previously established that AraR is indeed a DNA-
binding protein (27) and that arabinose is the specific effector
that modulates its DNA-binding activity and its ability to
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FIG. 2. Sequence alignment of AraR-like proteins and three members of the GntR family (N-terminal region) or two members of LacI/GalR
family (C-terminal region) and one periplasmic binding protein. Residues that are typical of the entire GntR or LacI/GalR family are depicted with
gray characters on a black background; residues characteristic of AraR homologous proteins are highlighted with white characters on a gray
background (see Materials and Methods). Positions of AraR mutations obtained by random mutagenesis (circles) or site-directed mutagenesis
(triangles) are shown. Black triangles or circles represent mutations leading to a constitutive phenotype, and open triangles or circles denote
changes that resulted in an AraR superrepressor phenotype. Letters representing the introduced residues are shown above the symbols. The
secondary structures (arrows represent beta strands; bars represent alpha-helices) of FadR (amino acid residues 1 to 73) and PurR (positions 60
to 296) are shown below the alignment according to van Aalten et al. (54) and Schumacher et al. (50), respectively. The microorganisms of source
and accession numbers are as follows: B. su, B. subtilis (P96711); B. li, B. licheniformis (Q62R80 and Q62UH0); B. hd, B. halodurans (Q9KBQ0);
B. st, Geobacillus stearothermophilus (Q9S470); C. ac, Clostridium acetobutylicum (Q97JE6); E. fa, Enterococcus faecium (gi48825728); P. pe,
Pediococcus pentosaceus (gi48870639); L. pl, Lactobacillus plantarum (Q88S80); O. ih, Oceanobacillus iheyensis (Q8EMP1); HutC P. pu, histidine
utilization repressor of Pseudomonas putida (P22773); GntR, B. su gluconate utilization repressor of B. subtilis (P10585); FadR E. co, fatty-acid
metabolism regulator of E. coli (P09371); LacI E. co, lactose repressor of E. coli (P03023); RbsB E. co, ribose-binding protein of E. coli (P02925);
PurR E. co, purine repressor of E. coli (P15030).
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repress transcription from the ara promoters (26, 27). AraR is
presumed to act as a dimer due to the dyad symmetry of its
target sequences and the existence of a potential HTH motif,
both features commonly observed in bacterial transcription
repressors that bind DNA as homodimers or homotetramers
(30). Gel filtration and glutaraldehyde cross-linking experi-
ments carried out previously suggested that AraR is able to
multimerize in solution, but the results were not conclusive
(27; L. J. Mota and I. de Sa´-Nogueira, unpublished data). To
address this issue and to further distinguish functional domains
of AraR, chimeric fusions between the amino-terminal DBD
of LexA from E. coli and different portions of AraR were
constructed and analyzed. LexA is a repressor that binds to an
operator site in the promoter of sulA gene and represses tran-
scription. Binding to the DNA is dependent upon dimerization
of the C-terminal domain, which can be removed and replaced
FIG. 3. AraR modeling. A) Close-in view of the arabinose binding site on the C-terminal domain of AraR, highlighting in blue shades the
residues mutated by site-directed mutagenesis using the model and in green shades the residues found by random mutagenesis. Arabinose is
represented by balls and sticks, and the fold of the protein is represented by a tube. B) Colored molecular surface of the C-terminal domain of
AraR highlighting the residues potentially involved in the dimer contact and the mutations performed on them. The dimer contact is made up of
hydrophobic residues, surrounded by polar and charged residues. C) Close-in view of the N-terminal region of AraR, highlighting in blue shades
the residues mutated by site directed mutagenesis and in green shades the residues found by random mutagenesis. The fold of the protein is
represented by a tube. The structure is oriented so that the part interacting with the DNA (using the similarity with FadR) (29) is facing the viewer.
D) Schematic drawing of the domain structure of LacI/GalR repressors adapted from Lewis et al. (20). The DBDs, the N-terminal subdomains
(NSD) and the C-terminal subdomains (CSD), the effector binding cleft, and the hinge helix, which is formed upon operator binding and connects
the DBD to the core of the repressor, are indicated. Panels A, B and C were rendered with PyMol (6).
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with another protein or protein fragment (5). When ho-
modimerization of the fused moiety occurs it allows the chi-
meric LexA to repress expression from the sulA promoter. In
this study, the DBD of LexA (residues 1 to 87) was fused in-frame
to the full-length AraR protein (AraR1–362) and to three trun-
cated forms of the repressor (AraR76–362, AraR160–362, and
AraR258–362). The four LexA-AraR chimeras were indepen-
dently used to transform the E. coli reporter strain SU101
harboring a sulA-lacZ fusion. Chloramphenicol acetyltrans-
ferase, a characterized homotrimer (5), fused to the LexA
DBD was used as a positive control in these experiments. The
AraR1–362 and AraR76–362 chimeras were able to repress effi-
ciently the expression of the sulA-lacZ fusion, whereas
AraR160–362 and AraR258–362 had an intermediate effect (Table
3). The differences observed in the levels of repression be-
tween AraR160–362 and AraR258–362 could be due to misfolding
of the AraR160–362 region when fused to LexA. These results
indicate that AraR is able to form homodimers and suggest
that amino acid residues 76 to 362 comprise determinants
necessary for dimerization.
Mutagenesis of the araR allele and isolation of AraR defec-
tive (AraR) and superrepressor (AraRs) mutants. To further
identify regions in AraR involved in DNA and effector binding
or dimerization, we performed nonbiased random mutagenesis
of araR. We screened for mutations in araR leading to the
expression of a protein unable to bind DNA, dimerize, or fold
properly (constitutive phenotype [AraR]) and for mutations
that affect the ability of the repressor to bind or respond to
arabinose (superrepressor phenotype [AraRs]). The shuttle
plasmid pLS30 harboring the araR allele was the template for
random mutagenesis by PCR in the presence of MnCl2, ac-
cording to the method of Leung et al. (19). To facilitate down-
stream mutation mapping and sequencing analysis, pLS30 car-
ries two new restriction sites introduced in the araR allele by
silent mutagenesis using pLS24 (carrying the wild-type araR
allele) as a template (see Materials and Methods). The pres-
ence of these silent mutations did not interfere with the regu-
latory activity of AraR, as determined by comparing the -ga-
lactosidase activity of strains IQB351 and IQB352 (Table 1) in
the presence and absence of inducer (data not shown). This
procedure allowed the division of the araR gene into three
fragments flanked by unique restriction sites. The mutagenized
fragments were cloned back into pLS30. Three different librar-
ies of mutations were obtained after transforming E. coli, and
clones from each group were pooled and their DNA was ex-
tracted and used to transform B. subtilis strain IQB350 (Table
1). This strain bears an araAB-lacZ fusion and a deletion in
the araR gene that leads to constitutive expression of -galac-
tosidase. To establish a screening strategy, we confirmed that
when B. subtilis IQB350 was transformed with linearized plas-
mid (pLS30 or pLS24; see Materials and Methods) the araR
wild-type allele was integrated at the nonessential amyE locus
by a double-recombination event; consequently, the araAB-
lacZ expression was under the control of AraR. So the expres-
sion of the araR wild-type allele in these strains was responsible
for the white color of the colonies in a complex medium (SFA)
containing X-Gal and for the blue color in the same medium in
the presence of arabinose. However, when the integrated allele
expresses an AraR mutant form unable to bind DNA, dimer-
ize, or fold properly, the strain produces blue colonies in the
SFA medium without inducer, which is consistent with an
AraR phenotype. Deficiencies in response or binding to arab-
inose lead to the white color of the colonies in SFA medium
with inducer, which correlates with an AraRs phenotype. When
this screening strategy was used, several clones showing defects
with respect to the regulatory activity of AraR were isolated.
DNA sequencing confirmed the presence of single missense
mutations in the mutagenized fragments of 12 constitutive mu-
tants and four superrepressors. These 16 fragments were recov-
ered by subcloning into pLS30. The AraR mutations were as
follows: L-333S, F-373S, S-533P, Q-613R, I-823T,
E-1023Q, L-1573R, H-2263R, C-2713R, R-2853K,
I-3083T, and P-3193L. Superrepressor AraRs mutations were
as follows: T-873I, T-1173A, S-1463R, and D-2113G. The
resulting mutant proteins were designated for the mutated posi-
tion and amino acid substituted (e.g., AraRL33S).
In previous studies, B. subtilis mutants constitutive for arabi-
nose utilization and mutants showing growth deficiencies in
minimal medium with arabinose as the sole carbon source were
isolated after mutagenesis with N-methyl-N-nitro-N-ni-
trosoguanidine and mapped in the araR locus (33, 44). This
region of the chromosome was sequenced, and three novel
single missense mutations conferring an AraRs phenotype (E-
1423K, G-2153V, and G-2153D) and one responsible for a
constitutive phenotype AraR (G-1383E) were detected. The
DNA fragments carrying these mutations were also subcloned
into pLS30.
Mutations leading to inability to bind to the DNA (AraR)
map across the entire length of the primary sequence of AraR,
whereas mutations that affect the ability of the repressor to re-
spond to arabinose (AraRs) are clustered in the C-terminal region
TABLE 3. Repression of sulA-lacZ by LexA-AraR
chimeras in E. colia
Plasmid-encoded
LexA-AraR chimeras
-Galactosidase
activity
a Rectangles in black represent the LexA DNA-binding domain (LexA-DBD),
in white the chloramphenicol acetyl-transferase (Cat), and in grey the different
regions of AraR (numbers indicate amino acid residues). Full-length AraR
chimeras harboring single and double mutations (L114A and I89AL114A), ob-
tained by site-directed mutagenesis, are indicated. E. coli strains carrying the
correspondent plasmid-encoded chimeras were grown in LB and assayed for
-galactosidase activity (as described in Materials and Methods). Values are the
average and standard deviations of three independent experiments, each assayed
in duplicate.
VOL. 188, 2006 CHARACTERIZATION OF THE B. SUBTILIS REGULATOR AraR 3031
of AraR (Fig. 2). In addition to this collection of mutants pro-
duced by random mutagenesis, an in-frame deletion of the HTH
motif of AraR was generated in pLS30. The resulting araR allele
(AraR aa13–65) encodes a mutant AraR protein missing 53
residues at the N-terminal region (from S-13 to T-65) (Fig. 2).
In vivo characterization of the AraR mutants. B. subtilis
strain IQB350, carrying an araR deletion, was transformed
with the plasmids encoding the mutated araR alleles as de-
scribed in Materials and Methods (Table 1). The regulatory
activity of the AraR mutated proteins was analyzed in the
resulting strains by determination of the levels of accumulated
-galactosidase activity expressed from the araAB-lacZ fusion
under inducing (presence of arabinose) and noninducing (ab-
sence of arabinose) conditions. Strains IQB350 and IQB352
(araR wild-type allele) were used as controls. The results are
summarized in Fig. 4. The presence of the wild-type AraR
resulted in 98.6-fold repression, whereas in the araR-null mu-
tant (araR) regulation was completely abolished. All AraR
mutations displayed reduced regulatory activity. In mutants
AraRL33S, G138E, C271R, and I308T, only residual repression
or no repression was observed (Fig. 4A, top), whereas mutants
Q61R, E102Q, and R285K showed a less than twofold reduction
in repression. In the mutant AraRaa13–65, carrying an in-frame
deletion comprising the HTH motif, no regulatory activity was
detected (Fig. 4A). All AraRs showed inability to respond to
arabinose. The maximal value of increase in -galactosidase ac-
tivity in the presence of arabinose was 2.8-fold (D211G) com-
pared to 98.6-fold of the wild type (Fig. 4B, top).
The constitutive phenotype, absence of regulatory activity,
could be the result of deficient accumulation of mutant AraR
forms in the cell. Therefore, the abundance of each variant was
tested to identify mutations that affected the production of
stable AraR. The quantity of AraR was estimated by Western
blotting using AraR antiserum and equivalent amounts of
crude extracts of cells grown in inducing and noninducing
conditions. Strains IQB350 and IQB352 were used as controls;
the results of the Western blot analyses are shown in Fig. 5.
The cellular level of the wild-type AraR increased in inducing
conditions, which correlates with the negative regulation ex-
erted by AraR with respect to its own expression (42). Mutants
AraR aa13–65, AraRL33S, F37S, S53P, G138E, and C271R
exhibited noticeable defects in accumulation of AraR (Fig. 5),
suggesting a decrease of stability of these mutant forms of
AraR. However, this decrease in stability does not correlate in
all cases with the observed regulatory defect (see Discussion).
The level of accumulation of the variants Q61R, I82T, E102Q,
L157R, H226R, R285K, I308T, and P319L was comparable to
that seen with wild-type AraR.
Site-directed mutagenesis of AraR residues. The structure
of the modeled AraR sugar-binding pocket suggested that
amino acids F94, D212, Q214, R218, D301, and H318 might
contact arabinose (Fig. 3A). The construction of mutants
F94A, D212A, Q214A, R218L, D301N, and H318A directly
tested the prediction of the functional role of these residues.
Substitutions of amino acids were designed to minimize struc-
ture disruption. The model depicted in Fig. 3B indicated as
likely candidates for the dimerization interface a core of hy-
drophobic amino acid residues surrounded by polar and
charged residues. These amino acids were subjected to muta-
tional analysis and exchanged to I89A, Y92F, R99A, L114A,
and F305A. Residues most likely to be interacting with DNA
were also identified, and one of them, R45, located in the
recognition helix (Fig. 3C), was changed to alanine.
All these AraR mutants generated by site-directed mutagen-
FIG. 4. In vivo characterization of mutant AraR proteins. -Galac-
tosidase activities of B. subtilis strains carrying an araAB-lacZ fusion
and an araR allele integrated at the amyE locus and grown in the
absence or presence of arabinose (in gray and black bars, respectively)
are shown. Amino acid substitutions (obtained by random or site-
directed mutagenesis) leading to an AraR phenotype (A) or AraRS
phenotype (B) are indicated for the mutated position and substituted
amino acid by use of the standard one-letter designation. Values rep-
resent the averages of three independent experiments, each assayed in
duplicate. Error bars represent the standard deviation. R.F. indicates
the repression factor, calculated as the ratio between values obtained
in the presence and in the absence of inducer. M.U., Miller units.
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esis in plasmid pLS30 (Materials and Methods) were tested for
their regulatory activity in vivo after transformation of the B.
subtilis strain IQB350 (araR araAB-lacZ) as described above
(see Table 1). As predicted by the model, all mutants designed
to disrupt contact with the sugar, except H318A, displayed a
superrepressor phenotype (AraRs) by showing an inability to
respond to arabinose (Fig. 4B, bottom). In the AraR mutant
forms I89A, L114A, and F305A, constructed to prevent the
assembly of monomers, a lower level of repression or no re-
pression was observed (Fig. 4A, bottom). However, mutant
Y92F resulted in a less than twofold reduction in repression
and variant R99A displayed a level of regulation similar to that
of wild-type AraR. The AraR R45A variant, designed to pre-
vent binding to the DNA, exhibited a complete loss of regula-
tory activity (Fig. 4A, bottom). Additionally, the cellular abun-
dance of each mutant variant leading to decreased regulatory
activity, the constitutive (AraR) phenotype, was estimated by
Western blot analysis in crude cellular extracts as described
above. The results shown in Fig. 4 indicated that accumulation
of the mutant forms of repressor was comparable to that seen
with wild-type AraR.
The relevance of amino acids I89 and L114 in the assembly
of AraR dimer was further analyzed by constructing LexA-
AraR chimeras bearing mutations in these positions. An AraR
full-length chimera carrying a single L114A mutation did not
affect significantly the expression of the sulA-lacZ fusion com-
pared to the results seen with the wild type (Table 3). However,
a chimera bearing a double mutation, I89A and L114A, dis-
played a level of repression very similar to that constructed
with a truncated form of AraR258–362 (Table 3), indicating the
importance of these amino acids in the formation of dimers.
Negative transdominance of AraR mutants. B. subtilis strain
IQB101 (wild-type araR), harboring an araAB-lacZ fusion,
was transformed with the plasmids encoding selected AraR
mutants obtained by site-directed mutagenesis. The mutated
araR alleles, under the control of the IPTG-inducible Pspac
promoter, were integrated at the nonessential amyE locus of
the receptor strain by a double-recombination event. Since the
position of this locus is near the origin of replication of the
chromosome, more than one copy of the mutated allele is
expected to be present in the cell; additionally, the expression
of the mutated araR allele is under the control of the strong
Pspac promoter (11). Together, these conditions should lead to
an excess of the AraR mutant form over the wild type. A
significant decrease of regulatory activity was observed with
mutant R45A (affecting DNA binding), and loss of response to
arabinose was detected with mutant F94A, predicted to be
involved in binding of the sugar (Table 4). These results in-
dicate titration of the wild-type AraR by assembly of het-
erodimers with inactive mutant proteins. In contrast, mu-
tants I89A, L114A, and F305A were recessive, which is
consistent with the assigned role in dimerization for the
exchanged residues.
DISCUSSION
The B. subtilis AraR transcription factor plays an important
role in carbohydrate utilization by controlling the transport
and catabolism of arabinose and the uptake of xylose and
galactose, three structurally different sugars that often occur
associated in hemicelluloses. The mutational analysis pre-
sented here allowed the identification of the regions and spe-
cific amino acid residues involved in the different molecular
events underlying the mechanism of transcriptional repression
by AraR.
We used random mutagenesis of the araR allele and a ge-
netic approach to identify missense mutations that resulted in
a noninducible, superrepressor phenotype (AraRs). Addition-
ally, three other araR alleles conferring an AraRs phenotype
FIG. 5. AraR accumulation in the cell determined by Western im-
munoblot analysis. Equal amounts of the soluble fractions of cell
extracts obtained from B. subtilis cultures harboring a wild-type, mu-
tant, or no araR allele and grown in the absence () or presence ()
of inducer were prepared as described in Materials and Methods.
Mutant proteins are designated for the mutated position and substi-
tuted amino acid by use of the standard one-letter code.
TABLE 4. Transdominance of AraR mutants over the wild-type
AraR in B. subtilis a
Strain IPTG-induciblearaR allele
-Galactosidase activity
R.F.
ara ara
IQB579 3.8 
 0.4 400.8 
 21.1 107.6 
 16.4
IQB580 Wild type 3.8 
 0.5 245.6 
 13.7 65.5 
 11.2
IQB580 Wild type (no IPTG) 3.3 
 0.7 380.7 
 42.8 119.4 
 28.6
IQB584 F94A 3.1 
 0.7 4.5 
 0.6 1.5 
 0.2
IQB584 F94A (no IPTG) 3.6 
 0.7 360.1 
 10.9 103.3 
 18.5
IQB585 L114A 4.1 
 0.6 364.1 
 18.4 90.0 
 14.9
IQB591 I89A 4.0 
 0.7 311.4 
 31.5 80.0 
 13.1
IQB592 F305A 3.0 
 0.6 281.4 
 14.7 96.6 
 15.4
IQB581 R45A 68.7 
 2.9 435.9 
 16.2 6.4 
 0.2
IQB581 R45A (no IPTG) 4.4 
 0.7 387.7 
 21.3 90.2 
 16.7
a -Galactosidase activities (in Miller units) of B. subtilis strains carrying an
araAB-lacZ fusion and a Pspac-araR fusion integrated at the amyE locus and
grown in the absence or presence of arabinose (ara or ara) and in the
presence of IPTG, unless otherwise specified. The araR mutant alleles are indi-
cated for the mutated position and amino acid substituted in AraR by use of the
standard one-letter code. Values represent the averages and standard deviations
of three independent experiments, each assayed in duplicate. R.F. indicates the
repression factor, calculated as the ratio between values obtained in the presence
and in the absence of inducer.
VOL. 188, 2006 CHARACTERIZATION OF THE B. SUBTILIS REGULATOR AraR 3033
previously identified by Paveia and Archer (33) were charac-
terized in this work. The AraRs variants carrying single-amino-
acid substitutions, T87I, T117A, E142K, S146R, D211G,
G215V, and G215D, mapped in the carboxyl terminus of AraR
and in positions highly conserved among the AraR-like pro-
teins but not in other LacI/GalR family members (Fig. 2),
suggesting their importance in the AraR-specific protein func-
tion. The AraRs phenotype, quantified in vivo (Fig. 4B), could
be due either to a decreased ability to bind arabinose or to an
inability to undergo an allosteric transition that results in a
conformational change of the repressor preventing binding to
the cognate DNA. The three-dimensional structures of the
effector-binding domain determined for some members of the
LacI/GalR family show a common fold that is analogous to
those of periplasmic-binding proteins (9, 20, 34, 50), being
composed of two similar subdomains in whose interface is
located the effector-binding cleft (Fig. 3D). The structure of
the C-terminal domain of the E. coli PurR was used to model
the C-terminal part of AraR, and the arabinose-binding pocket
was modeled after the structure of the E. coli D-ribose binding
protein (see above). Based on this model the AraRs variants
isolated displayed substitutions in residues located close to the
arabinose cleft but not predicted to be in direct contact with
the effector molecule (Fig. 3A). The residues more likely to be
in contact with the sugar, F94, D212, Q214, R218, D301, and
H318, were mutagenized, and all except H318 resulted in a
noninducible AraRs phenotype (Fig. 3A). Mutations of the
corresponding residues in LacI (P76, S191, S193, R197, D274,
and Q291) (Fig. 2) also give a superrepressor phenotype except
mutations in Q291 and the precise change P76A (21, 31, 52).
Mutations in residues R196 and D275 of PurR (R218 and
D301 in AraR, respectively) (Fig. 2) also result in effector-
binding defects (49). Since the mutations introduced in AraR
were designed to minimize structure disruption and to probe
loss of contacts, the results obtained suggest that amino acids
F94, D212, Q214, R218, and D301 are directly involved in
sugar binding rather than participating in the allosteric transi-
tion mechanism. In summary, the random and site-directed
mutagenesis procedures and the subsequent in vivo analysis
of the mutants obtained confirmed that, as predicted by the
model, the effector-binding domain of AraR is comprised
within its C terminal.
A group of missense mutations in the araR allele leading to
a constitutive phenotype (AraR) were also isolated and/or
characterized. These mutations localized across the entire
length of the primary sequence of AraR (Fig. 2). The AraR
phenotype could be generated from a defect in specific func-
tions of the repressor, such as DNA binding or dimerization, or
by protein misfolding. The substitutions I82T, E102Q, G138E,
L157R, H226R, C271R, R285K, I308T, and P319L mapped in
the C-terminal region of AraR (Fig. 2). All mutant forms
showed reduced regulatory activity, which is completely abol-
ished in mutants G138E and C271R (Fig. 4A). The intracellu-
lar accumulation level of these mutant proteins was similar to
that observed in the wild-type AraR. The exceptions were
G138E and C271R, which accumulate at lower levels, presum-
ably due to the increase of proteolytic degradation (Fig. 5). In
these two mutants the defect in accumulation and the lack
of regulatory activity were comparable, suggesting that the
former caused the latter. Based on the model the exchanges
I82T, E102Q, H226R, C271R, I308T, and P319L are localized
in the hydrophobic core of the protein and most probably
affect the fold (data not shown). In variants L157R, R285K,
and I308T, substitutions are solvent exposed; consequently, the
reason for the phenotype displayed is unclear. However, it is
noteworthy that R285K and I308T are positioned near the
dimer interface.
The members of the group of constitutive mutants L33S,
F37S, S53P, and Q61R, isolated after random mutagenesis, are
discussed together because the substitutions mapped at the N
terminus of AraR (Fig. 2). This region comprises a DNA-
binding motif representative of the GntR family of bacterial
regulatory proteins (10). The exchanges L33S and F37S re-
sulted in complete loss of regulatory activity, while a twofold
reduction was observed with S53P (Fig. 4A). These results do
not correlate with the intracellular accumulation of the pro-
teins. In fact, whereas a drastic reduction was observed with
mutants L33S and S53P, only a light decrease in the amount of
F37S was detected (Fig. 5). The regulatory activity of Q61R,
which accumulated at levels similar to those seen with the wild
type, decreased less than twofold. In addition, a mutant lacking
53 residues comprising the helix-turn-helix motif was gener-
ated and characterized in vivo. Although this variant showed
only a small decrease in accumulation in vivo, the regulatory
activity was completely abolished (Fig. 4A and Fig. 5). The
N-terminal region of AraR was modeled using the structure of
the E. coli transcription factor FadR, the only member of the
GntR family with the structure determined (54, 58). The DNA-
binding domain contains an HTH motif of the “winged” type
(4, 8). Based on the model only Q61 is predicted to contact the
DNA in the minor groove (Fig. 3C), and exchanges of the corre-
sponding residue in FadR (H75) and GntR (R75), the gluco-
nate repressor from B. subtilis, were shown to have a trans-
dominant negative phenotype (35, 59). In FadR this residue is
at the tip of the wing and buried deep in the minor groove (58).
The exchanges L33S and F37S, located in the second helix,
may influence binding of other amino acids to the DNA, and
S53P makes the third helix, the recognition helix, shorter. The
specific role of residue R45 in AraR, predicted to be in contact
with the DNA, was tested by exchange to an alanine (Fig. 3C).
This mutation led to complete loss of regulatory activity, al-
though it accumulated at wild-type levels (Fig. 4A and Fig. 5).
The involvement of this particular residue in AraR-DNA bind-
ing is further supported by the transdominant negative pheno-
type of the araR R45A allele in B. subtilis (Table 4) and vali-
dates the model presented in this work. The corresponding
residue in FadR (R49) (Fig. 2) was shown to be in contact with
the DNA by crystal data and mutational analysis (35, 58).
On the basis of studies performed with E. coli by construc-
tion and expression of LexA-AraR chimeric fusions, we show
that AraR is able to dimerize in vivo (Table 3). Furthermore,
the analysis of different chimeras with truncated versions of
AraR suggests that amino acid residues 76 to 362 include
determinants necessary for dimerization. The model derived
for the C-terminal region of the protein predicts candidate
residues for the dimer interface (Fig. 3B) that were mu-
tagenized, and the variants were analyzed according to both
regulatory activity and in vivo accumulation. All accumulated
at levels comparable to that of the wild type (Fig. 5), and
mutants I89A, L114A, and F305A showed severe defects in
3034 FRANCO ET AL. J. BACTERIOL.
their repression capacity whereas Y92F displayed only a two-
fold reduction in the regulatory activity (Fig. 4A). In addition,
the relevance of residues I89 and L114 in the assembly of
monomers was confirmed by constructing LexA-AraR chime-
ras bearing mutations in these positions. An AraR full-length
chimera bearing a double mutation, I89A and L114A, affected
the expression of the sulA-lacZ fusion similarly to the chimera
constructed with the truncated version AraR258–362 (Table 3).
The role of residues I89, L114, and F305 in dimerization is
further supported by the classical transdominance experiments
(12). In this work we show that alleles containing either mu-
tations involved in sugar binding and response or in DNA
binding are dominant over the wild-type allele in B. subtilis
whereas alleles bearing the exchanges I89A, L114A, and
F305A are recessive (Table 4). Interestingly, in CcpA, the
master regulator of carbon catabolite repression in B. subtilis
and a member of the LacI/GalR family, the corresponding
residues (I71, L96, and L280; not shown) are predicted on the
basis of the crystal structure determined for the C-terminal
region to be involved in dimerization (48). The homology be-
tween the C terminus of AraR and proteins of the LacI/GalR
family allows predicting the location of the arabinose-binding
site of AraR between the two C subdomains in the effector-
binding cleft (Fig. 3D). Accordingly, the allosteric transition
triggered by arabinose can be expected to occur by a mecha-
nism showing similarities to that described for LacI and PurR,
the only two full-length members of this family bound to the
DNA with structures available. In LacI, the binding of IPTG
causes a small motion of the C subdomains, which alters the
dimer interface within the N-terminal subdomain (1, 2, 20),
leading to the disruption of the interaction between the hinge
helices that make important contacts with the minor groove.
This frees the DNA binding HTH domain, which becomes
disordered (1, 2, 20). PurR-specific binding to the DNA is
mediated by either guanine or hypoxanthine. Similarly to the
effector-bound form of LacI, the corepressor-free PurR shows
a rotation of the C subdomains that results in the destabiliza-
tion of the hinge helices and disruption of specific DNA bind-
ing (49, 50). Since the DNA-binding domain of AraR is not
homologous to the members of the LacI/GalR family, the
hinge helix that plays a fundamental role in DNA recognition
and in the allosteric transition may be absent in AraR, antic-
ipating differences in the allosteric mechanism triggered by
arabinose relative to that described for the LacI/GalR pro-
teins. Thus, the rare modular structure of AraR that combines
functional domains from different origins (GntR family and
LacI/GalR family) allows hypothesizing a novel mechanism of
effector-regulated specific DNA binding. To elucidate the
mechanisms of transcriptional regulation by AraR and extend
the mutation analysis presented in this report, attempts to
determine the crystal structure of free AraR, AraR-DNA com-
plexes, and AraR bound to arabinose are currently in progress.
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